Market Cap ₹2946 Cr.
Stock P/E 0.0
P/B 21.5
Current Price ₹1184.9
Book Value ₹ 55
Face Value 10
52W High ₹1226.8
Dividend Yield 0.35%
52W Low ₹ 175
Jeena Sikho Lifecare Ltd is a healthcare company based in India that offers a range of products and services focused on improving the health and well-being of individuals. The company's primary focus is on providing affordable and accessible healthcare solutions to underserved communities. Jeena Sikho Lifecare Ltd operates through a network of clinics and pharmacies, as well as online platforms, offering services such as health check-ups, diagnostics, medicine delivery, and telemedicine consultations. The company also offers health insurance and wellness programs to promote preventive care and lifestyle changes. With a commitment to quality and patient-centered care, Jeena Sikho Lifecare Ltd aims to become a trusted healthcare partner for people across India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|
| Net Sales | 147 | 205 | |
| Other Income | 1 | 3 | |
| Total Income | 148 | 207 | |
| Total Expenditure | 128 | 159 | |
| Operating Profit | 20 | 48 | |
| Interest | 1 | 1 | |
| Depreciation | 3 | 3 | |
| Exceptional Income / Expenses | 0 | 0 | |
| Profit Before Tax | 15 | 44 | |
| Provision for Tax | 4 | 11 | |
| Profit After Tax | 11 | 34 | |
| Adjustments | 0 | 0 | |
| Profit After Adjustments | 11 | 34 | |
| Adjusted Earnings Per Share | 6.2 | 13.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 39% | 0% | 0% | 0% |
| Operating Profit CAGR | 140% | 0% | 0% | 0% |
| PAT CAGR | 209% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 554% | NA% | NA% | NA% |
| ROE Average | 41% | 36% | 36% | 36% |
| ROCE Average | 53% | 45% | 45% | 45% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 |
|---|---|---|
| Shareholder's Funds | 37 | 126 |
| Minority's Interest | -0 | 0 |
| Borrowings | 1 | 1 |
| Other Non-Current Liabilities | 0 | -0 |
| Total Current Liabilities | 24 | 25 |
| Total Liabilities | 62 | 151 |
| Fixed Assets | 29 | 60 |
| Other Non-Current Assets | 11 | 13 |
| Total Current Assets | 22 | 77 |
| Total Assets | 62 | 151 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 |
|---|---|---|
| Opening Cash & Cash Equivalents | 9 | 2 |
| Cash Flow from Operating Activities | 16 | 15 |
| Cash Flow from Investing Activities | -18 | -33 |
| Cash Flow from Financing Activities | -5 | 48 |
| Net Cash Inflow / Outflow | -7 | 29 |
| Closing Cash & Cash Equivalent | 2 | 32 |
| # | Mar 2022 | Mar 2023 |
|---|---|---|
| Earnings Per Share (Rs) | 6.17 | 13.59 |
| CEPS(Rs) | 7.97 | 14.77 |
| DPS(Rs) | 0 | 2 |
| Book NAV/Share(Rs) | 20.06 | 50.6 |
| Core EBITDA Margin(%) | 12.35 | 22.39 |
| EBIT Margin(%) | 11.11 | 22.1 |
| Pre Tax Margin(%) | 10.3 | 21.63 |
| PAT Margin (%) | 7.64 | 16.37 |
| Cash Profit Margin (%) | 9.9 | 17.94 |
| ROA(%) | 18.19 | 31.6 |
| ROE(%) | 30.66 | 41.31 |
| ROCE(%) | 37.03 | 53.05 |
| Receivable days | 22.52 | 27.73 |
| Inventory Days | 15.83 | 9.32 |
| Payable days | 111.95 | 112.53 |
| PER(x) | 0 | 11.84 |
| Price/Book(x) | 0 | 3.18 |
| Dividend Yield(%) | 0 | 0.69 |
| EV/Net Sales(x) | 0.1 | 1.8 |
| EV/Core EBITDA(x) | 0.76 | 7.61 |
| Net Sales Growth(%) | 0 | 39.71 |
| EBIT Growth(%) | 0 | 177.98 |
| PAT Growth(%) | 0 | 199.47 |
| EPS Growth(%) | 0 | 120.2 |
| Debt/Equity(x) | 0.2 | 0.01 |
| Current Ratio(x) | 0.9 | 3.15 |
| Quick Ratio(x) | 0.64 | 2.98 |
| Interest Cover(x) | 13.76 | 47.75 |
| Total Debt/Mcap(x) | 0 | 0 |
| # | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter | 65.89 | 66.2 | 67.91 | 67.91 |
| FII | 0 | 0 | 2 | 0.26 |
| DII | 0 | 0 | 0.04 | 0 |
| Public | 34.11 | 33.8 | 30.05 | 31.83 |
| Others | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 |
| # | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter | 0.91 | 0.91 | 0.94 | 1.69 |
| FII | 0 | 0 | 0.03 | 0.01 |
| DII | 0 | 0 | 0 | 0 |
| Public | 0.47 | 0.47 | 0.42 | 0.79 |
| Others | 0 | 0 | 0 | 0 |
| Total | 1.38 | 1.38 | 1.38 | 2.49 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
